The organization opposes joint procurement for generic medicines, citing COVID-19 ICU medicine procurement failures. They request exclusivity clauses, transparent tender processes, and volume commitments. They also call for a coordinated EU medicine reserve with clear cost responsibilities and rolling reserves to prevent waste. This would prevent inventory blockage and reduce financial risks from unused stockpiles.
Patients risk medicine shortages when parallel procurement creates supply chain stress and volatility.